Authors
Kurane, IchiroMatsutani, Takaji
Suzuki, Ryuji
Takasaki, Tomohiko
Kalayanarooj, Siripen
Green, Sharone
Rothman, Alan L.
Ennis, Francis A.
UMass Chan Affiliations
Center for Infectious Disease and Vaccine ResearchDepartment of Medicine, Division of Infectious Diseases and Immunology
Document Type
Journal ArticlePublication Date
2011-12-01
Metadata
Show full item recordAbstract
Dengue virus (DENV) is a leading cause of morbidity and mortality in most tropical and subtropical areas of the world. Dengue virus infection induces specific CD4+CD8- and CD8+CD4- T cells in humans. In primary infection, T-cell responses to DENV are serotype cross-reactive, but the highest response is to the serotype that caused the infection. The epitopes recognized by DENV-specific T cells are located in most of the structural and non-structural proteins, but NS3 is the protein that is most dominantly recognized. In patients with dengue hemorrhagic fever (DHF) caused by secondary DENV infection, T cells are highly activated in vivo. These highly activated T cells are DENV-specific and oligoclonal. Multiple kinds of lymphokines are produced by the activated T cells, and it has been hypothesized that these lymphokines are responsible for induction of plasma leakage, one of the most characteristic features of DHF. Thus, T-cells play important roles in the pathogenesis of DHF and in the recovery from DENV infection.Source
Trop Med Health. 2011 Dec;39(4 Suppl):45-51. Epub 2011 Dec 1. Link to article on publisher's siteDOI
10.2149/tmh.2011-S09Permanent Link to this Item
http://hdl.handle.net/20.500.14038/50983PubMed ID
22500136Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.2149/tmh.2011-S09
